A COMPARISON OF THE EFFICACY AND SAFETY OF COMBINED HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) AND HIGHLY PURIFIED URINARY FOLLICLE STIMULATING HORMONE (HP-UFSH) VERSUS HP-HMG ALONE FOR OVARIAN STIMULATION.

被引：1
|
作者：
Miller, C. E. [1 ]
Shapiro, D. [1 ]
Witz, C. A. [2 ]
Willey, R. [3 ]
Heiser, P. W. [3 ]
Ruman, J. [3 ]
Yankov, V. I. [3 ]
机构：
[1] Charles Miller & Associates, Naperville, IL USA
[2] Houston Fertil Inst, Houston, TX USA
[3] Ferring Pharmaceut Inc, Parsippany, NJ USA
来源：
FERTILITY AND STERILITY | 2015年 / 104卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2015.07.1008
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-631
引用
收藏
页码：E322 / E323
页数：2
相关论文
共 50 条
  • [1] HIGHLY PURIFIED HUMAN MENOTROPIN (HP-hMG) VERSUS RECOMBINANT FOLLICLE STIMULATING HORMONE (rFSH): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Agramunt, S.
    Checa, M. A.
    Espinos, J. J.
    Requena, A.
    Carreras, R.
    FERTILITY AND STERILITY, 2010, 94 (04) : S253 - S253
  • [2] Highly purified human menopausal gonadotrophin (HP-hMG, Menopur) as a ready-to-use solution for injection in prefilled pen is bioequivalent to HP-hMG powder for reconstitution
    Jonker, D. M.
    Koch, M.
    Larsson, P.
    Ravi, A.
    Rasmussen, B. B.
    Speer, R.
    Mannaerts, B. M. J. L.
    HUMAN REPRODUCTION, 2021, 36 : 404 - 404
  • [3] Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
    Khair, Andrew
    Brown, Tray
    Markert, Marie
    Barsoe, Carsten Rodseth
    Daftary, Gaurang S. S.
    Heiser, Patrick W. W.
    PHARMACOECONOMICS-OPEN, 2023, 7 (05) : 851 - 860
  • [4] Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
    Andrew Khair
    Tray Brown
    Marie Markert
    Carsten Rødseth Barsøe
    Gaurang S. Daftary
    Patrick W. Heiser
    PharmacoEconomics - Open, 2023, 7 : 851 - 860
  • [5] Comparison of in vitro fertilization (IVF) outcomes in patients treated with highly purified urinary follicle stimulating hormone (HP-Ufsh) plus human menopausal Gonadotropins (hMG) or follitropin α (r-hFSH) plus hMG.
    Sakkas, D
    Anderson, W
    Arici, A
    FERTILITY AND STERILITY, 2005, 83 : S15 - S16
  • [6] COST-EFFECTIVENESS OF A HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLE-STIMULATING HORMONE (RFSH) IN PATIENTS PARTICIPATING IN AN ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROGRAM
    Vicente, C.
    Poon, Y.
    Piwko, C.
    VALUE IN HEALTH, 2010, 13 (03) : A183 - A183
  • [7] A PROSPECTIVE RANDOMIZED TRIAL TO COMPARE RECOMBINANT FOLLICLE STIMULATING HORMONE (RFSH) VERSUS HIGHLY PURIFIED HUMAN MENOTROPIN (HP-HMG) FOR CONTROLLED OVARIAN STIMULATION ON BLASTOCYST ANEUPLOIDY RATES.
    Anderson, S.
    Norris, H.
    Hartlein, T.
    Davies, E. B.
    Brasile, D.
    Gocial, B.
    Orris, J. J.
    Glassner, M. J.
    FERTILITY AND STERILITY, 2018, 110 (04) : E201 - E201
  • [8] COST COMPARISON OF HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLE-STIMULATING HORMONE (RFSH) FOR CONTROLLED OVARIAN STIMULATION IN US HIGH-RESPONDER PATIENTS BASED ON THE MEGASET-HR TRIAL.
    Khair, Andrew F.
    Brown, Tray
    Markert, Marie
    Samuelsen, Carl H.
    Barsoe, Carsten
    Daftary, Gaurang S.
    Heiser, Patrick W.
    FERTILITY AND STERILITY, 2021, 116 (03) : E267 - E267
  • [9] Added value of anti-Mueurollerian hormone serum concentration in assisted reproduction clinical practice using highly purified human menopausal gonadotropin (HP-hMG)
    Barriere, Paul
    Porcu-Buisson, Geraldine
    Avril, Catherine
    Hamamah, Samir
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2022, 51 (02)
  • [10] Predicted high-responder women diagnosed with oligoovulation may benefit from stimulation with highly purified human menopausal gonadotrophin (HP-hMG)
    Heiser, P.
    Foster, E.
    Sinha, A.
    Elci, O.
    Daftary, G.
    HUMAN REPRODUCTION, 2020, 35 : 6 - 6
12345